We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Web Microsite Introduces Single Cell Gene Expression Profiling

By LabMedica International staff writers
Posted on 22 Dec 2009
A Web microsite introduces the rapidly expanding field of single cell gene expression profiling.

Historically, gene expression profiling of single cells, such as stem cells, circulating tumor and formalin-fixed, paraffin-embedded (FFPE) tissues has been difficult and expensive to perform. More...
Now, however, results from single-cell samples can be obtained easily and inexpensively using the Fluidigm Corp's (South San Francisco, CA, USA) BioMark system and the company's Dynamic Array integrated fluidic circuits (IFCs). Dynamic Array IFCs are ideally suited for high-throughput cell-line studies to determine individual cell behavior in a homozygous population.

Visitors to Fluidigm Web site (see below) can gain an understanding of the technology, find out how international scientists using Fluidigm Dynamic Array chips are accelerating their research, and evaluate whether IFC technology is suitable for their project.

A five-minute audiovisual presentation provides an informative introduction to how IFC technology is now providing a practical means of studying single cells A wide selection of downloadable customer conference posters, peer-reviewed publications, success stories and application notes describe the technology in action and the benefits it is delivering to leading laboratories around the world.

Fluidigm develops, manufactures, and markets proprietary IFC systems that improve productivity in life-science research. Fluidigm's IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in extremely minute volumes. These "integrated circuits for biology” are made possible by miniaturizing and integrating liquid-handling components on a single microfabricated microfluidic device. Fluidigm's IFC systems, consisting of instrumentation, software, and single-use IFCs, increase throughput, decrease costs, and enhance sensitivity compared to conventional laboratory systems. Fluidigm products have not been cleared or approved by the U.S. Food and Drug Administration (FDA) for use as a diagnostic and are only available for research use.

Related Links:
Fluidigm single cell analysis presentation
Fluidigm



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.